236 related articles for article (PubMed ID: 24201293)
1. Prevalence and heterogeneity of circulating tumour cells in metastatic cutaneous melanoma.
Khoja L; Shenjere P; Hodgson C; Hodgetts J; Clack G; Hughes A; Lorigan P; Dive C
Melanoma Res; 2014 Feb; 24(1):40-6. PubMed ID: 24201293
[TBL] [Abstract][Full Text] [Related]
2. Analysis of circulating tumor cells in patients with non-small cell lung cancer using epithelial marker-dependent and -independent approaches.
Krebs MG; Hou JM; Sloane R; Lancashire L; Priest L; Nonaka D; Ward TH; Backen A; Clack G; Hughes A; Ranson M; Blackhall FH; Dive C
J Thorac Oncol; 2012 Feb; 7(2):306-15. PubMed ID: 22173704
[TBL] [Abstract][Full Text] [Related]
3. Biomarker utility of circulating tumor cells in metastatic cutaneous melanoma.
Khoja L; Lorigan P; Zhou C; Lancashire M; Booth J; Cummings J; Califano R; Clack G; Hughes A; Dive C
J Invest Dermatol; 2013 Jun; 133(6):1582-90. PubMed ID: 23223143
[TBL] [Abstract][Full Text] [Related]
4. Circulating tumor cells as prognostic biomarkers in cutaneous melanoma patients.
Kiyohara E; Hata K; Lam S; Hoon DS
Methods Mol Biol; 2014; 1102():513-22. PubMed ID: 24258996
[TBL] [Abstract][Full Text] [Related]
5. Phenotypic and genetic heterogeneity of tumor tissue and circulating tumor cells in patients with metastatic castration-resistant prostate cancer: A report from the PETRUS prospective study.
Massard C; Oulhen M; Le Moulec S; Auger N; Foulon S; Abou-Lovergne A; Billiot F; Valent A; Marty V; Loriot Y; Fizazi K; Vielh P; Farace F
Oncotarget; 2016 Aug; 7(34):55069-55082. PubMed ID: 27391263
[TBL] [Abstract][Full Text] [Related]
6. Application of a filtration- and isolation-by-size technique for the detection of circulating tumor cells in cutaneous melanoma.
De Giorgi V; Pinzani P; Salvianti F; Panelos J; Paglierani M; Janowska A; Grazzini M; Wechsler J; Orlando C; Santucci M; Lotti T; Pazzagli M; Massi D
J Invest Dermatol; 2010 Oct; 130(10):2440-7. PubMed ID: 20535130
[TBL] [Abstract][Full Text] [Related]
7. Usefulness of monitoring circulating tumor cells as a therapeutic biomarker in melanoma with BRAF mutation.
Kiniwa Y; Nakamura K; Mikoshiba A; Ashida A; Akiyama Y; Morimoto A; Okuyama R
BMC Cancer; 2021 Mar; 21(1):287. PubMed ID: 33731038
[TBL] [Abstract][Full Text] [Related]
8. Multimarker real-time reverse transcription-PCR for quantitative detection of melanoma-associated antigens: a novel possible staging method.
Arenberger P; Arenbergerova M; Gkalpakiotis S; Lippert J; Stribrna J; Kremen J
J Eur Acad Dermatol Venereol; 2008 Jan; 22(1):56-64. PubMed ID: 18181974
[TBL] [Abstract][Full Text] [Related]
9. Recent advances and prospects in the isolation by size of epithelial tumor cells (ISET) methodology.
Ma YC; Wang L; Yu FL
Technol Cancer Res Treat; 2013 Aug; 12(4):295-309. PubMed ID: 23448577
[TBL] [Abstract][Full Text] [Related]
10. Prognostic value of microphthalmia-associated transcription factor and tyrosinase as markers for circulating tumor cells detection in patients with melanoma.
Samija I; Lukac J; Marić-Brozić J; Buljan M; Alajbeg I; Kovacević D; Situm M; Kusić Z
Melanoma Res; 2010 Aug; 20(4):293-302. PubMed ID: 20357686
[TBL] [Abstract][Full Text] [Related]
11. Monitoring changes in circulating tumour cells as a prognostic indicator of overall survival and treatment response in patients with metastatic melanoma.
Klinac D; Gray ES; Freeman JB; Reid A; Bowyer S; Millward M; Ziman M
BMC Cancer; 2014 Jun; 14():423. PubMed ID: 24915896
[TBL] [Abstract][Full Text] [Related]
12. Clinical significance and molecular characteristics of circulating tumor cells and circulating tumor microemboli in patients with small-cell lung cancer.
Hou JM; Krebs MG; Lancashire L; Sloane R; Backen A; Swain RK; Priest LJ; Greystoke A; Zhou C; Morris K; Ward T; Blackhall FH; Dive C
J Clin Oncol; 2012 Feb; 30(5):525-32. PubMed ID: 22253462
[TBL] [Abstract][Full Text] [Related]
13. Isolation and characterization of circulating melanoma cells by size filtration and fluorescent in-situ hybridization.
Yanagita M; Luke JJ; Hodi FS; Jänne PA; Paweletz CP
Melanoma Res; 2018 Apr; 28(2):89-95. PubMed ID: 29406397
[TBL] [Abstract][Full Text] [Related]
14. A pilot study to explore circulating tumour cells in pancreatic cancer as a novel biomarker.
Khoja L; Backen A; Sloane R; Menasce L; Ryder D; Krebs M; Board R; Clack G; Hughes A; Blackhall F; Valle JW; Dive C
Br J Cancer; 2012 Jan; 106(3):508-16. PubMed ID: 22187035
[TBL] [Abstract][Full Text] [Related]
15. S100 serum level: a tumour marker for metastatic melanoma.
Bottoni U; Izzo P; Richetta A; Mannooranparampil TJ; Devirgiliis V; Del Giudice M; Reale MG; Frati L; Calvieri S
Melanoma Res; 2003 Aug; 13(4):427-9. PubMed ID: 12883371
[No Abstract] [Full Text] [Related]
16. Circulating melanoma cells and survival in metastatic melanoma.
Rao C; Bui T; Connelly M; Doyle G; Karydis I; Middleton MR; Clack G; Malone M; Coumans FA; Terstappen LW
Int J Oncol; 2011 Mar; 38(3):755-60. PubMed ID: 21206975
[TBL] [Abstract][Full Text] [Related]
17. Detection of circulating tumor cells as a prognostic factor in patients undergoing radical surgery for non-small-cell lung carcinoma: comparison of the efficacy of the CellSearch Assay™ and the isolation by size of epithelial tumor cell method.
Hofman V; Ilie MI; Long E; Selva E; Bonnetaud C; Molina T; Vénissac N; Mouroux J; Vielh P; Hofman P
Int J Cancer; 2011 Oct; 129(7):1651-60. PubMed ID: 21128227
[TBL] [Abstract][Full Text] [Related]
18. A novel approach using telomerase-specific replication-selective adenovirus for detection of circulating tumor cells in breast cancer patients.
Kim SJ; Masago A; Tamaki Y; Akazawa K; Tsukamoto F; Sato J; Ozawa T; Tsujino Y; Noguchi S
Breast Cancer Res Treat; 2011 Aug; 128(3):765-73. PubMed ID: 21630023
[TBL] [Abstract][Full Text] [Related]
19. Comparison of two detection systems for circulating tumor cells among patients with renal cell carcinoma.
Bai M; Zou B; Wang Z; Li P; Wang H; Ou Y; Cui K; Bian J; Li S; Xu X
Int Urol Nephrol; 2018 Oct; 50(10):1801-1809. PubMed ID: 30120680
[TBL] [Abstract][Full Text] [Related]
20. Circulating Melanoma Cell Subpopulations: Their Heterogeneity and Differential Responses to Treatment.
Gray ES; Reid AL; Bowyer S; Calapre L; Siew K; Pearce R; Cowell L; Frank MH; Millward M; Ziman M
J Invest Dermatol; 2015 Aug; 135(8):2040-2048. PubMed ID: 25830652
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]